,,ii  #aaith ,,congress  #ast ,session  
,s4 #cbji  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,november #ai1 
#bjbe,mrs4 ,capito 7for herself1 ,mrs4  
,shaheen1 ,mr4 ,cramer1 ,mr4 ,king1 ,mr4
 ,hoeven1 ,mrs4 ,gillibrand1 ,mr4       
,ricketts1 ,ms4 ,klobuchar1 ,mr4        
,justice1 ,mr4 ,kaine1 ,mrs4 ,britt1    
,mr4 ,van ,hollen1 ,mr4 ,hagerty1 ,mr4  
,kelly1 ,mr4 ,scott of ,south ,carolina1
 ,ms4 ,cortez ,masto1 and ,ms4 ,rosen7  
introduced the following bill2 which was
 read twice and referred to the         
,committee on ,veterans' ,affairs  ,a   
,,bill  ,to amend title #ch1 ,united    
,states ,code1 to ensure that the       
,secretary of ,veterans ,affairs        
furnishes certain non-opioid pain       
medications to veterans1 and for other  
purposes4  #a4 ,short title ,this ,act  
may be cited as the ,non-,opioids       
,prevent ,addiction in the ,nation for  
,veterans ,act or the ,,nopain for      
,veterans ,act4  #b4 ,inclusion of      
certain non-opioid pain medications in  

the ,national ,formulary of the         
,department of ,veterans ,affairs  7a7  
,in general ,section #habe of title #ch1
 ,united ,states ,code1 is amended--    
7#a7 in subsection 7d71 by adding at the
 end the following new paragraph3  7#d7 
,the term non-opioid pain management    
drug or biological product means a drug 
or biological product approved1 granted1
 or cleared by the ,food and ,drug      
,administration to reduce postoperative 
pain1 to produce postsurgical or        
regional analgesia1 or to treat acute   
pain1 without acting upon the body's    
opioid receptors4  2  7#b7 by           
redesignating subsection 7d71 as so     
amended1 as subsection 7e72 and  7#c7 by
 inserting after subsection 7c7 the     
following new subsection 7d73  7d7 ,the 
,secretary shall include a non-opioid   
pain management drug or biological      
product in the national formulary of the
 ,department not later than the earlier 
of-- 7#a7 one year after the date on    
which the non-opioid pain management    

drug or biological product becomes      
eligible for temporary additional       
payment under section #ahcc7t77#af77;,g7
 of the ,social ,security ,act 7#db     
,u4,s4,c4 #aciel7t77#af77;,g77 or       
eligible for separate payment under     
section #daf4agd of title #db1 ,code of 
,federal ,regulations 7or successor     
regulations72 or  7#b7 #ah months after 
the date on which the non-opioid pain   
management drug or biological product is
 approved by the ,food and ,drug        
,administration4  4  7b7 ,limitation    
,none of the funds in the ,cost of ,war 
,toxic ,exposures ,fund under section   
#cbd of title #ch1 ,united ,states      
,code1 may be used to carry out the     
amendments made by this section4  7c7   
,implementation ,not later than #ij days
 after the date of the enactment of this
 ,act1 the ,secretary of ,veterans      
,affairs shall implement the amendments 
made by this section4